KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Gross Margin (2016 - 2026)

Zimmer Biomet Holdings has reported Gross Margin over the past 18 years, most recently at 72.39% for Q1 2026.

  • For Q1 2026, Gross Margin rose 119.0% year-over-year to 72.39%; the TTM value through Mar 2026 reached 70.03%, down 102.0%, while the annual FY2025 figure was 69.71%, 176.0% down from the prior year.
  • Gross Margin for Q1 2026 was 72.39% at Zimmer Biomet Holdings, up from 64.68% in the prior quarter.
  • Over five years, Gross Margin peaked at 72.88% in Q1 2024 and troughed at 64.68% in Q4 2025.
  • A 5-year average of 71.08% and a median of 71.49% in 2025 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: soared 271bps in 2023 and later crashed -632bps in 2025.
  • Year by year, Gross Margin stood at 71.49% in 2022, then grew by 1bps to 72.23% in 2023, then decreased by -2bps to 71.0% in 2024, then dropped by -9bps to 64.68% in 2025, then grew by 12bps to 72.39% in 2026.
  • Business Quant data shows Gross Margin for ZBH at 72.39% in Q1 2026, 64.68% in Q4 2025, and 72.05% in Q3 2025.